Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol‐induced hepatocyte steatosis and apoptosis

Alcoholic liver disease (ALD), characterized by excessive deposition of lipids in hepatocytes, causes heavy health burden personally and socially. Mechanistically, hedgehog signaling was activated during the development of ALD, and exerted compelling role in regulating lipometabolism. The current promising intervention strategy is inhibition of lipid accumulation and apoptosis in hepatocytes. Magnesium isoglycyrrhizinate (MgIG) has been widely used in various liver diseases for its good hepatoprotective activities. However, the role of MgIG in ALD has not been elucidated. Therefore, this study was aimed to explore the role of MgIG and further identify the potential mechanisms. We found for the first time that MgIG reduced lipid accumulation, including triglyceride, and total cholesterol, probably via inducing peroxisome proliferator‐activated receptor‐alpha and inhibiting sterol regulatory element‐binding protein‐1c. Further, MgIG alleviated ethanol‐induced oxidative stress, evidenced by reduced abundance of reactive oxygen species and increased levels of glutathione, superoxide dismutase, and mitochondrial transmembrane potential. Besides, MgIG protected hepatocytes from ethanol‐induced apoptosis. In addition, MgIG dose‐dependently suppressed hedgehog signaling. Of note was that disruption of hedgehog signaling could mimic the effects of MgIG, whereas activation of hedgehog signaling abrogated the effects of MgIG. These findings suggested that MgIG prevented ethanol‐induced hepatocyte steatosis and apoptosis via a hedgehog signaling inhibition‐dependent mechanism. © 2017 IUBMB Life, 69(7):540–552, 2017

[1]  E. El-demerdash,et al.  Forskolin, a hedgehog signalling inhibitor, attenuates carbon tetrachloride‐induced liver fibrosis in rats , 2016, British journal of pharmacology.

[2]  Feng Zhang,et al.  Nrf2 Knockdown Disrupts the Protective Effect of Curcumin on Alcohol-Induced Hepatocyte Necroptosis. , 2016, Molecular pharmaceutics.

[3]  G. Addolorato,et al.  Treatment of alcohol use disorders in patients with alcoholic liver disease. , 2016, Journal of hepatology.

[4]  Feng Zhang,et al.  Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR‐S1PR2‐dependent mechanism , 2016, IUBMB life.

[5]  S. Dash,et al.  Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease , 2016, Hepatology.

[6]  L. Dubuquoy Lipocalin 2 highlights the complex role of neutrophils in alcoholic liver disease. , 2016, Journal of hepatology.

[7]  D. Calvisi,et al.  Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model. , 2016, Journal of hepatology.

[8]  Feng Zhang,et al.  Ligustrazine prevents alcohol-induced liver injury by attenuating hepatic steatosis and oxidative stress. , 2015, International immunopharmacology.

[9]  Feng Zhang,et al.  Tetramethylpyrazine prevents ethanol-induced hepatocyte injury via activation of nuclear factor erythroid 2-related factor 2. , 2015, Life sciences.

[10]  Feng Zhang,et al.  Curcumin attenuates ethanol‐induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes , 2015, IUBMB life.

[11]  M. Moreno-Aliaga,et al.  Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes. , 2015, Free radical biology & medicine.

[12]  Sen Lu,et al.  Magnesium isoglycyrrhizinate protects hepatic L02 cells from ischemia/reperfusion induced injury. , 2014, International journal of clinical and experimental pathology.

[13]  G. Karaca,et al.  Alcohol activates the hedgehog pathway and induces related procarcinogenic processes in the alcohol-preferring rat model of hepatocarcinogenesis. , 2014, Alcoholism, clinical and experimental research.

[14]  Vandana Singh,et al.  Double Recombinant Mycobacterium bovis BCG Strain for Screening of Primary and Rationale-Based Antimycobacterial Compounds , 2013, Antimicrobial Agents and Chemotherapy.

[15]  Feng Zhang,et al.  Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity. , 2013, Chemico-biological interactions.

[16]  A. Suzuki,et al.  Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease , 2012, Hepatology.

[17]  T. Zeng,et al.  Garlic oil alleviated ethanol-induced fat accumulation via modulation of SREBP-1, PPAR-α, and CYP2E1. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[18]  R. Bataller,et al.  Alcoholic liver disease: pathogenesis and new therapeutic targets. , 2011, Gastroenterology.

[19]  Q. Anstee,et al.  Genetics of alcoholic and nonalcoholic fatty liver disease. , 2011, Seminars in liver disease.

[20]  A. Diehl,et al.  The role of Hedgehog signaling in fibrogenic liver repair. , 2011, The international journal of biochemistry & cell biology.

[21]  F. Parhami,et al.  Hedgehog signaling and osteogenic differentiation in multipotent bone marrow stromal cells are inhibited by oxidative stress , 2010, Journal of cellular biochemistry.

[22]  Jun Ren,et al.  Alcohol and Acetaldehyde in Public Health: From Marvel to Menace , 2010, International journal of environmental research and public health.

[23]  Chunyan Liu,et al.  Hepatitis B viral X protein alters the biological features and expressions of DNA repair enzymes in LO2 cells , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[24]  G. Gores,et al.  Mechanisms and clinical implications of hepatocyte lipoapoptosis , 2010, Clinical lipidology.

[25]  Yuan Cheng,et al.  Prevention of Free Fatty Acid-Induced Hepatic Lipotoxicity in HepG2 Cells by Magnesium Isoglycyrrhizinate in vitro , 2009, Pharmacology.

[26]  M. Katoh,et al.  Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. , 2009, International journal of oncology.

[27]  L. Rubbia‐Brandt,et al.  Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. , 2008, Gastroenterology.

[28]  Ting-kai Li Quantifying the risk for alcohol‐use and alcohol‐attributable health disorders: Present findings and future research needs , 2008, Journal of gastroenterology and hepatology.

[29]  Lungen Lu,et al.  Phase I Safety and Pharmacokinetic Study of Magnesium Isoglycyrrhizinate After Single and Multiple Intravenous Doses in Chinese Healthy Volunteers , 2007, Journal of clinical pharmacology.

[30]  W. Bushman Hedgehog Signaling in Development and Cancer , 2007 .

[31]  I. Blair Endogenous glutathione adducts. , 2006, Current drug metabolism.

[32]  N. Kaplowitz,et al.  Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. , 2006, Journal of hepatology.

[33]  D. Crabb,et al.  Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. , 2004, Alcohol.

[34]  P. Haber,et al.  Pathogenesis and management of alcoholic hepatitis , 2003, Journal of gastroenterology and hepatology.